PACS PACS Group, Inc.

PACS plans to acquire operations of 32 Florida skilled nursing facilities, adding 4,049 licensed beds and establishing a statewide network.

PACS Group, Inc. (NYSE:PACS) shares rose 3.

Ensign Group's rising occupancy, acquisitions and real-estate growth support its outlook, while reimbursement and cost pressures remain risks.

CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.

CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.

PACS Group shares have rebounded after a Medicare billing scandal, with strong Q2 earnings and Buy ratings, though DOJ and SEC investigations and shareholder lawsuits remain unresolved.

In early August 2026, PACS Group, Inc. reported second-quarter results showing revenue of US$1,428 million and net income of US$76.37 million, and raised its full-year 2026 revenue guidance to a range of US$5.75 billion to US$5.85 billion from US$5.65 billion to US$5.75 billion. Despite authorizing a buyback earlier in the year, PACS Group did not repurchase any shares through June 30, 2026, suggesting management is currently prioritizing operating growth and earnings performance over...

The consensus price target hints at a 25.7% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Net income surged 49.8% while adjusted EBITDA margin expanded 150 basis points.

Biodesix (BDSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

PACS Group (NYSE:PACS) reported second-quarter 2026 revenue growth of 9.1% and adjusted EBITDA growth of 25% from a year earlier, citing higher occupancy, improved skilled nursing patient mix and continued progress across acquired facilities as they mature within its operating model. Revenue for th

PACS Group Inc (PACS) reports a 9.1% revenue increase and raises full-year guidance, driven by robust same-store growth and strategic acquisitions.

Moby summary of PACS Group, Inc.'s Q2 2026 earnings call

PACS Group, Inc. (PACS) delivered earnings and revenue surprises of +14.55% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

PACS vs. ALHC: Which Stock Is the Better Value Option?

PACS vs. ALHC: Which Stock Is the Better Value Option?

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.